Master the Design Controls Process with Automation & Planning
InfoStrength, an industry-leading provider of on-demand business solutions for regulated companies, today announced the fourth in its series of webinars specifically designed to benefit the Life Science executive titled “Master the Design Controls Process with Automation and Planning.”
Research Triangle Park, NC – 18 Mar 2009: InfoStrength, an industry-leading provider of on-demand business solutions for regulated companies, today announced the fourth in its series of webinars specifically designed to benefit the Life Science executive titled “Master the Design Controls Process with Automation and Planning.”
“Our company charter is to develop solutions that enable life-science companies to thrive,” said Rita Geiger, Founder and CEO of InfoStrength. “That charter maps directly to developing and delivering both solutions and practical strategies that enable the acceleration of product commercialization in the Life Sciences.”
Dr. Cynthia Pritchard, President and CEO, and Dr. Billy Usrey, COO, of BioTechnology Transfer will lead a discussion the on the FDA requirement to establish and maintain the procedures to control the design of medical devices and biologics in order to ensure that specified design requirements are met. Compliance with this regulatory mandate is often viewed to be a daunting task.
“With the proper approach and the effective use of technology”, explains Dr. Prichard, “Organizations can not only easily achieve compliance, but also realize tremendous operational benefits.”
Join us as we talk about how a best-practice design control strategy can truly accelerate the commercialization process. We will review design control basics and importance, discuss the risks of not leveraging design controls, walk through potential pitfalls and challenges, and detail best practices for the use of design controls. For information or to sign up, please visit us
CLICK HERE.
About InfoStrength
InfoStrength®, Inc., an industry thought leader serving biotechnology, pharmaceutical and medical device companies with internationally recognized regulatory expertise, developed InfoStrength® Smart Enterprise Suite (SES) with an innovative software development methodology specifically created for FDA regulated environments. InfoStrength SES is a configurable, modular, web-based application solution specifically designed to address business and regulatory initiatives of life science companies. InfoStrength® SES enables sharing critical information while ensuring Intellectual Property management control, milestone accountability and market differentiating collaboration. The InfoStrength® solution delivers document, project and process management along with regulatory compliance controls and a robust validation package. Additional information about InfoStrength can be obtained from the company's website on the Internet at
www.infostrength.com.
Return to News Releases